Cell Biology
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tumor necrosis factor ligand superfamily member 11(TNFSF11) | Login | Tumor necrosis factor ligand superfamily member 11(TNFSF11) | ||||||||||||||||
|
||||||||||||||||||
Tumor necrosis factor receptor superfamily member 19L(Relt) | Login | Tumor necrosis factor receptor superfamily member 19L(Relt) | ||||||||||||||||
|
||||||||||||||||||
Tumor necrosis factor receptor superfamily member 6(FAS) (Gln26-Asn173) | Login | Tumor necrosis factor receptor superfamily member 6(FAS) (Gln26-Asn173) | ||||||||||||||||
|
||||||||||||||||||
Vimentin Protein (VIM) | Login | Vimentin Protein (VIM) | ||||||||||||||||
|
||||||||||||||||||
Epidermal growth factor receptor(EGFR) | Login | Epidermal growth factor receptor(EGFR) | ||||||||||||||||
|
||||||||||||||||||
Cyclin-dependent kinase 4 inhibitor B(CDKN2B) | Login | Cyclin-dependent kinase 4 inhibitor B(CDKN2B) | ||||||||||||||||
|
||||||||||||||||||
Fibroblast growth factor 21(FGF21)(29-210) | Login | Fibroblast growth factor 21(FGF21)(29-210) | ||||||||||||||||
|
||||||||||||||||||
Interleukin-2 receptor subunit alpha(IL2RA) | Login | Interleukin-2 receptor subunit alpha(IL2RA) | ||||||||||||||||
|
||||||||||||||||||
Fresolimumab Biosimilar - Anti-TGFB, TGF beta mAb - Research Grade | Login | Fresolimumab Biosimilar - Anti-TGFB, TGF beta mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Fresolimumab Biosimilar - Anti-TGFB, TGF beta mAb - Research Grade | Login | Fresolimumab Biosimilar - Anti-TGFB, TGF beta mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Conatumumab Biosimilar - Anti-TNFRSF10B, CD262 mAb - Research Grade | Login | Conatumumab Biosimilar - Anti-TNFRSF10B, CD262 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Conatumumab Biosimilar - Anti-TNFRSF10B, CD262 mAb - Research Grade | Login | Conatumumab Biosimilar - Anti-TNFRSF10B, CD262 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Netakimab Biosimilar - Anti-IL17A mAb - Research Grade | Login | Netakimab Biosimilar - Anti-IL17A mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Netakimab Biosimilar - Anti-IL17A mAb - Research Grade | Login | Netakimab Biosimilar - Anti-IL17A mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Bersanlimab Biosimilar - Anti-ICAM1, CD54 mAb - Research Grade | Login | Bersanlimab Biosimilar - Anti-ICAM1, CD54 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Bersanlimab Biosimilar - Anti-ICAM1, CD54 mAb - Research Grade | Login | Bersanlimab Biosimilar - Anti-ICAM1, CD54 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Etokimab Biosimilar - Anti-IL33 mAb - Research Grade | Login | Etokimab Biosimilar - Anti-IL33 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Etokimab Biosimilar - Anti-IL33 mAb - Research Grade | Login | Etokimab Biosimilar - Anti-IL33 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb - Research Grade | Login | Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb - Research Grade | Login | Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Galcanezumab Biosimilar - Anti-CALCA, CGRP1, CALCB, CGRP2 mAb - Research Grade | Login | Galcanezumab Biosimilar - Anti-CALCA, CGRP1, CALCB, CGRP2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Galcanezumab Biosimilar - Anti-CALCA, CGRP1, CALCB, CGRP2 mAb - Research Grade | Login | Galcanezumab Biosimilar - Anti-CALCA, CGRP1, CALCB, CGRP2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Erenumab Biosimilar - Anti-CALCRL, CGRP-R mAb - Research Grade | Login | Erenumab Biosimilar - Anti-CALCRL, CGRP-R mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Erenumab Biosimilar - Anti-CALCRL, CGRP-R mAb - Research Grade | Login | Erenumab Biosimilar - Anti-CALCRL, CGRP-R mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Fremanezumab Biosimilar - Anti-CALCA , CALCB mAb - Research Grade | Login | Fremanezumab Biosimilar - Anti-CALCA , CALCB mAb - Research Grade | ||||||||||||||||
|